Table 1.
Demographic and Baseline Characteristics
| DPOS | Placebo | |||||||
|---|---|---|---|---|---|---|---|---|
|
Triptan‐Experienced n = 286 |
Triptan Naïve n = 342 |
Nausea
†
n = 391 |
No Nausea n = 237 |
Triptan‐Experienced n = 284 |
Triptan Naïve n = 360 |
Nausea
†
n = 392 |
No Nausea n = 252 |
|
| Age, mean (SD) | 42.4 (11.4) | 37.7 (11.1) | 39.8 (11.2) | 40.1 (12.0) | 42.7 (11.0) | 37.3 (11.0) | 39.4 (11.0) | 40 (12.3) |
| Male, n (%) | 36 (12.6) | 54 (15.8) | 45 (11.5) | 45 (19.0) | 31 (12.0) | 62 (17.2) | 40 (10.2) | 56 (22.2) |
| Race, n (%) | ||||||||
| White | 276 (96.5) | 284 (83.0) | 351 (89.8) | 209 (88.2) | 266 (93.7) | 306 (85.0) | 350 (89.3) | 222 88.1) |
| Black/African American | 5 (1.7) | 48 (14.0) | 31 (7.9) | 22 (9.3) | 13 (4.6) | 47 (13.1) | 34 (8.7) | 26 (10.3) |
| Asian | 2 (0.7) | 1 (0.3) | 1 (0.3) | 2 (0.8) | 0 | 3 (0.8) | 3 (0.8) | 0 (.0) |
| Other | 3 (1) | 9 (2.6) | 8 (2.0) | 4 (1.7) | 5 (1.8) | 4 (1.1) | 5 (1.3) | 4 (1.6) |
| Presence of nausea, n (%) | 174 (60.8) | 217 (63.5) | 391 (100.0) | 0 (.0) | 167 (58.8) | 225 (62.5) | 392 (100.0) | 0 (.0) |
| Presence of photophobia, n (%) | 239 (83.6) | 278 (81.3) | 335 (85.7) | 182 (76.8) | 233 (82.0) | 280 (77.8) | 323 (82.4) | 190 (75.4) |
| Presence of phonophobia, n (%) | 219 (76.6) | 253 (74.0) | 298 (76.2) | 174 (73.4) | 217 (76.4) | 271 (75.3) | 307 (78.3) | 181 (71.8) |
| Vomiting, n (%) | 10 (3.5) | 20 (5.8) | 26 (6.6) | 4 (1.7) | 13 (4.6) | 24 (6.7) | 30 (7.7) | 7 (2.8) |
†At time of dosing. DPOS = diclofenac potassium for oral solution.